Webcast Introduction

Trans-catheter aortic valve implantation (TAVI) develops rapidly in recent years. With its more and more mature technique, TAVI has opened a new era of valve disease treatment. This procedure has been carried out widely in western countries. Since March 2010 when Academician JunboGe led his team to successfully carry out the first TAVI, many centers in China started to perform this procedure and have made remarkable achievements.

Columbia HeartSource has rich experience and globally leading expertise in TAVI. Academician JunboGe and Professor YingqiangGuo (West China Hospital of Sichuan University) will join hands with Professor Allan Schwartz and Professor Craig Smith from Columbia HeartSource to have an in-depth conversation on the clinical application and skills on TAVI, and current status of TAVI at home and abroad.

Drvoice.cn will live webcast this excellent activity. You’re welcome to view it and have interactions with the experts.

Program

The Application & Development of TAVI in China and abroad
13:30-16:00    
Time
Speaker
Content
13:00-13:30
All
Sign In
13:30-13:35
 
Opening Video
13:35-13:45
Prof. Sun Li Zhong
Opening Remarks
13:45-14:15
Prof. Guo Ying Qiang
Past and Future of Trans-Catheter valves
14:15-14:45
Prof. Ge Jun Bo
The development of TAVI in China
14:45-15:15
Craig R. Smith, MD
Expansion of TAVR into Low and Intermediate Risk Patients
15:15-15:45
Allan Schwartz, MD
Future Directions in Transcatheter Valve Therapies
15:45-16:00
Prof. Sun Li Zhong,Prof. Ge Jun Bo,Allan Schwartz, MD,Craig R. Smith, MD
Panel Discussion

Experts Introduction

  • Junbo Ge
    Zhongshan Hospital, Fudan University

    CMO of DeltaHealth Hospital. Academician, Chinese Academy of Sciences(CAS). Chairman, Chinese Society of Cardiology. Areas of Expertise: Complex coronary heart disease &structured cardiac disease intervention. Professor Ge has long been dedicated to innovating clinical techniques in cardiovascular disease and research. Professor Ge was the first to perform Transcatheter Aortic Value Implantation (TAVI) in 2010, and Mitra Clip in 2012 in China. He made huge contributions in the study of intravascular ultrasound, research and development of new coronary stent, and prevention and treatment of in-stent restenosis. 

  • 心脏大血管外科主任,医学博士,博士后。教授,主任医师,博士研究生导师。

    四川省卫生计生委学术技术带头人;美国胸外科医师协会(STS)会员;国际微创心胸外科学会(ISMICS)会员;中华医学会胸心血管外科分会青年委员会副主任委员;四川省医学会胸心外科专委会常委;《中国胸心血管外科临床杂志》编委。

    2014 年带领华西医院心脏团队实施了全国首例经心尖主动脉瓣膜植入术(TAVI),迄今共进行95例,是全球最大病例数量的主动脉瓣膜关闭不全的TAVI手术中心;近2年以第一/通讯作者在JACC、Int J Cardio上发表TAVI相关学术研究文章7篇,单篇最高17.8分,累计54分。郭应强教授受邀在ISMICS,ACVTS 和TCT 等国际会议上作大会发言,并受邀前往加拿大St.Paul Hospital 参与了J Valve 在美洲首例手术的实施,把“中国的心脏团队”、“中国产品”推向世界顶级舞台。在国内,郭应强教授成功举办经外科路径TAVI培训班7期,培训了来自12个省,18 家医院的团队进行该项目手术。


  • Chief, Division of Cardiology
    Physician-In-Chief, Vivian & Seymour Family Milstein Heart Center
    Vice Chair, Department of Medicine Seymour Milstein Harold Ames and
    Hatch Professor of Clinical Medicine
     
    Dr. Schwartz has been the driving force behind the development of the New York-Presbyterian/Columbia University Medical Center Cardiovascular Service Line and the new Vivian and Seymour Milstein Family Heart Center, of which he is Physician‐In‐Chief. 
    Under Dr. Schwartz’s leadership, there has been a major increase in the breadth of cardiology and research activities, resulting in the Division of Cardiology’s attaining international prominence and emerging as one of the leading cardiology training centers in the United States.
  • Johnson & Johnson Distinguished Professor

    Valentine Mott Professor of Surgery

    Chair, Department of Surgery, Columbia University

    Surgeon-in-Chief, Seymour Milstein Family Heart Hospital

    NewYork Presbyterian Hospital/Columbia University Medical Center


    Dr. Smith’s clinical practice is focused on valve repair and replacement, coronary bypass procedures, and operations involving the thoracic aorta.
    Dr. Smith is the Surgical Principal Investigator of the PARTNER Trial, a major international trial comparing conventional aortic valve replacement to percutaneous valve replacement.